Primers, Plasmids and Strains.
The primers used in this study were synthesized by eurofins MWG GmbH. The forward primer was designed to incorporate an N-terminal 6xHisTag into the DnaE construct. Table 1 shows the details of the primers used in this study. A pACYC184-11b (18) driven plasmid encoding full length β-clamp was donated by Dr. Karen A. Bunting (University of Nottingham UK). The plasmid was termed herein as pACYC11-dnaN. Plasmid pET11 (Novagen) was used for the expression of 6xHisTagged dnaE905hM. For cloning, DH5α chemically competent E. coli was used. For expression, chemically competent E. coli B834 (DE3) cells containing an isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible T7 RNA polymerase for expression of target genes cloned in pET vectors was used.
Table 1
Details of the primers used in this study. CATATG = NdeI, GGATCC = BamHI
Construct
|
Primer
|
Primer sequence
|
dnaEΔ905H
905–1160 (768bp)
|
E905h-f
|
GGAATTCCATATGCATCATCATCATCATCATGCGTTAAAAGCGGCAG
|
E905h-r
|
CCCGGATCCTTATTAGTCAAACTCCAGTTCC
|
dnaΔ905h-mut
|
BC-f
|
GCGGAAGCTATCGGTCAGCTGGATCTGTTCGGCGTGCTCGCCGAAG
|
Amplification of DnaE905.
Using primers E905f and E905r, (Table.1), and E. coli genomic DNA as template, the region of dnaE encoding C-terminal 255 residues was amplified with N-terminal 6x histidine. The amplified product was cloned into pET-11 expression vectors using NdeI and BamHI restriction sites separately. The resulting plasmid was named pAPdnaE905h. DH5α cells were used for cloning and amplification of these plasmids. The presence of original wild type sequences of inserts in appropriate orientations was confirmed by DNA sequencing.
Mutagenesis of DnaE905h
Mutagenesis of the internal clamp binding motif (iCBM) in pAPdnaE905h was performed using a primer designed to incorporate the desired base changes (i-CBMCf, Table 1) and the Quickchange Multi-Site-Directed Mutagenesis Kit (Stratagene) as explained in (16). The resulting plasmid having desired mutations was termed as pAP-dnaE905hM.
Protein Over-expression
(a) Over-Expression of β-clamp. Plasmid pACYC11-dnaN encoding full length β-clamp was transformed into E. coli B834 (DE3) expression strain [23]. Fresh transformants were grown in LB broth containing chloramphenicol (34 µg/ml) at 37°C. At OD600 = 0.6–0.8 the cells were induced with 0.1 mM IPTG, and were further incubated overnight at 25°C. The cells were then harvested by centrifugation, lysed by sonication in buffer A (50 mM HEPES pH 7.0, 200 mM NaCl, 20 mM imidazole). The soluble fraction was then obtained by centrifugation at 15,000 x g for 30 min at 4°C.
(b) Over-Expression and Solubilization of DnaE905hM. Plasmid pAP-dnaE905hM encoding C-terminal 255 residues of DnaE with N-terminal 6x histidine and bearing consensus iCBM was transformed into E. coli B834 (DE3) expression strain [23]. Fresh transformants were grown in LB broth containing ampicillin (100µg/ml) at 37°C. At OD600 = 0.6–0.8 the cells were induced with 0.1 mM IPTG, and were further incubated overnight at 25°C. The cells were then harvested by centrifugation, lysed by sonication in buffer A (50 mM HEPES pH 7.0, 200 mM NaCl, 20 mM imidazole). The in-soluble fraction was then obtained by centrifugation at 15,000 x g for 30 min at 4°C. The insoluble fraction containing over-expressed DnaE905h-mut was denatured in solublization buffer (50 mM HEPES (pH 7.0), 1 M NaCl, 40 mM imidazole, 6Murea)
Affinity Column For On-column Re-folding And Complex Formation
A 5ml Nickel based HisTrap column (GE Healthcare) was used for Nickel-based affinity purification. The column was equilibrated with 10-column volume of Binding buffer (50 mM HEPES (pH 7.0), 1 M NaCl, 40 mM imidazole, 6Murea). 10 ml of urea-denatured DnaE905hM was injected for binding, and the column was washed with 10-column volume of Re-folding buffer (50 mM HEPES (pH 7.0), 1 M NaCl, 40 mM imidazole) to achieve on-column refolding through a decreasing gradient of denaturant (programmed on AKTA Prime Plus system-GE Healthcare). 10ml of either clarified soluble fraction containing β-clamp was injected in the column manually at the rate of 0.5ml/min. The column was further washed in 10 column volume of Re-folding buffer and the complex was eluted in 5 column volume of elution buffer (50 mM HEPES (pH 7.0), 1 M NaCl, 300 mM imidazole) (programmed on AKTA Prime Plus system-GE Healthcare.
Size Exclusion Chromatography
A 26/60 Superdex 200 preparative column (GE Healthcare) was equilibrated in size exclusion buffer (HEPES 50 mM NaCl 250 mM ) and run according to Method programmed on AKTA Prime Plus system-GE Healthcare.
SDS-PAGE and Western Blot analysis. 10% poly-acrylamide gels (Severn Biotech) were set in 1.0 mm cassettes (Invitrogen) 1 X SDS running buffer was used. 15 µl of each protein sample was mixed with 5 µl of gel loading dye boiled and run. The program was set at 125 Volts for 1 hour 20 min. For western blotting. Xcell II Blot Module (Invitrogen) was used for western blotting the. The protein bands were transferred to nitrocellulose membrane in 1 X transfer buffer at 25 Volts for 1 hour 30 min. 10 ml of 5% milk protein in phosphate buffer saline (PBS)-Tween 20 were used as blocking buffer for 15 min. For 6xHisTagged DnaE905hM the blot was incubated with 1/1000 diluted alkaline-phosphatase- conjugated Mouse Anti-Hexa-His antibodies (Sigma) for 1 hour. The blot was washed with 10-15ml of PBS-Tween 20, three times for 5 min each time, and once with PBS. The blot was then developed using BCIP/NBT substrate (Sigma). For β-clamp the blot was incubated with 1.5 µl of rabbit polyclonal anti β-clamp IgG antibody (Primary antibody – donated by Dr. Jody Winter) for 1 hour. The blot was washed in a similar way as stated above. 1.5 µl of donkey anti-rabbit IgG alkaline phosphatase-conjugated antibodies (Secondary antibody) were then added. Once again the washing was achieved in a similar way. The blot was then developed using BCIP/NBT substrate (Sigma)